L'intérêt à découvert pour SailPoint donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de SailPoint. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

SailPoint (NASDAQ:SAIL) Stock, Rapport sur les intérêts à découvert

SAILPOINT INC

SailPoint

SailPoint Technologies

SailPoint Inc delivers solutions to enable comprehensive identity security for the enterprise. The company does this by unifying identity data across systems and identity types, including employee identities, non-employee identities, and machine identities. The SaaS and customer-hosted offerings of the company leverage intelligent analytics to give organizations critical visibility into which identities currently have access to which resources, which identities should have access to those resources, and how that access is being used. Its solutions enable organizations to establish, control, and automate policies that help them define and maintain a robust security posture and achieve regulatory compliance.

Macro Economic Events

News

Econ #s

Economics

USA Gasoline Inventories 4.188M Barrel Build Vs 0.660M Barrel Build Est.

EIA Weekly Distillates Stocks 1.710M Barrel Draw Vs 1.650M Barrel Draw Est.

Macro Notification

General

USA Crude Oil Inventories 3.845M Barrel Build Vs 3.500M Barrel Draw Est.

Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) has outperformed the market over the past 10 years by 3.88% on an annualized basis producing an average annual return of 15.39%. Currently, Verisk Analytics has a market capitalization of $43.42 billion. 
Buying $1000 In VRSK: If an investor had bought $1000 of VRSK stock 10 years ago, it would be worth $4,164.72 today based on a price of $310.42 for VRSK at the time of writing.
<h3>Verisk Analytics's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751466613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

VRSK

Here's How Much $1000 Invested In Verisk Analytics 10 Years Ago Would Be Worth Today

WIIM

NTRB

Nutriband shares are trading higher after the company announced it approved a 25% preferred stock dividend.

BMO Capital analyst Keith Bachman maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Outperform and raises the price target from $235 to $245.

Price Target

Analyst Ratings

ORCL

BMO Capital Maintains Outperform on Oracle, Raises Price Target to $245

Politics

President Trump Posts On Truth Social "THE ONE BIG BEAUTIFUL DEAL IS ALL ABOUT GTOWTH. IF PASSED, AMERICA WILL HAVE AN ECONOMIC RENAISSANCE LIKE NEVER BEFORE. IT IS ALREADY HAPPENING, JUST IN ANTICIPATION OF THE BEAUTIFUL BILL. DEFICIT CUT IN HALF, RECORD INVESTMENT — CASH, FACTORIES, JOBS POURING INTO THE USA. MAGA!!!"

<a href="https://truthsocial.com/@realDonaldTrump/posts/114784098546698642" title="https://truthsocial.com/@realDonaldTrump/posts/114784098546698642">https://truthsocial.com/@realDonaldTrump/posts/114784098546698642</a>

Global

President Trump Posts On Truth Social "I just made a Trade Deal with Vietnam. Details to follow!"

BMO Capital analyst Jack Matten maintains Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) with a Underperform and raises the price target from $15 to $23.

LMND

BMO Capital Maintains Underperform on Lemonade, Raises Price Target to $23

Scotiabank analyst Greg Harrison maintains Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) with a Sector Outperform and raises the price target from $32 to $35.

ARCT

Scotiabank Maintains Sector Outperform on Arcturus Therapeutics, Raises Price Target to $35

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) with a Outperform and raises the price target from $26 to $27.

BMRC

Keefe, Bruyette & Woods Maintains Outperform on Bank of Marin, Raises Price Target to $27

Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) will release earnings results for the fourth quarter, before the <a href="https://www.benzinga.com/quote/CAG/earnings">opening bell on Thursday, July 10.</a>
Analysts expect the Chicago, Illinois-based company to report quarterly earnings at 61 cents per share, versus 61 cents per share in the year-ago period. Conagra Brands projects to report quarterly revenue at $2.88 billion, compared to $2.91 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 25, Conagra Brands announced it will complete the removal of certified food, drug, and cosmetic colors from its U.S. frozen product portfolio by the end of 2025.
Conagra Brands shares rose 2.8% to close at $21.05 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/cag/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>B of A Securities analyst Bryan Spillane downgraded the stock from Neutral to Underperform and cut the price target from $27 to $20 on June 12, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Goldman Sachs analyst Leah Jordan downgraded the stock from Neutral to Sell and slashed the price target from $26 to $21 on June 9, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and decreased the price target from $27 to $23 on June 2, 2025. This analyst has an accuracy rate of 61%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $26 to $25 on May 6, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Equal-Weight rating and a price target of $27 on March 24, 2025. This analyst has an accuracy rate of 70%.</li>
</ul>
Considering buying CAG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-1024x586.png" alt="" class="wp-image-969600" style="width:598px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02002310/image-14.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Conagra Brands Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

CYCC

Cyclacel Pharmaceuticals share are trading lower after the company announced a 1-for-15 reverse stock split.

U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Wednesday.
Shares of Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) rose sharply during Wednesday's session after announcing a key <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46218060/hut-8s-ontario-power-plants-secure-long-term-contracts-stock-soars">infrastructure win in Ontario.</a>
The company revealed that its joint venture, Far North Power Corp., formed alongside Macquarie Equipment Finance Ltd., a subsidiary of Macquarie Group, has secured new five-year capacity agreements for all four of its Ontario-based natural gas power plants.
Hut 8 shares jumped 15.2% to $21.28 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) gained 56.88% to $112.84 after jumping 74% on Tuesday.</li>
<li>Namib Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMM#NASDAQ">NAMM</a>) rose 45.8% to $10.02 after declining 9% on Tuesday.</li>
<li>The Greenbrier Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) surged 16.5% to $54.74 after the company posted stronger-than-expected results for the third quarter.</li>
<li>Ramaco Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>) gained 16.2% to $11.60.</li>
<li>Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) rose 15.3% to $3.1350.</li>
<li>Precigen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) rose 13.6% to $1.65.</li>
<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) gained 13.4% to $17.35.</li>
<li>Sionna Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SION#NASDAQ">SION</a>) rose 10.5% to $20.07.</li>
<li>Montauk Renewables, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) gained 10.4% to $2.63.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) rose 9.4% to $3.5760.</li>
<li>MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) gained 7.1% to $16.81.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46218048/how-to-earn-500-a-month-from-microsoft-stock-4">How To Earn $500 A Month From Microsoft Stock</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

CRML

MARA

METC

MNTK

NAMM

PGEN

PRME

SION

Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday

Scotiabank analyst Orest Wowkodaw maintains Arizona Metals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AMC#TSX">AMC</a>) with a Sector Outperform and lowers the price target from C$3.75 to C$2.5.

TSX:AMC

Scotiabank Maintains Sector Outperform on Arizona Metals, Lowers Price Target to C$2.5

CRIS

Curis shares are trading lower after the company announced a $7 million registered direct offering and concurrent private placement.

Raymond James analyst Savanthi Syth reiterates Ryanair Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) with a Strong Buy and raises the price target from $60 to $70.

Reiteration

RYAAY

Raymond James Reiterates Strong Buy on Ryanair Hldgs, Raises Price Target to $70

Legal

SNAP

Fox Business Reports Snap Issues Statement On Utah Lawsuit, Says ".. Now, Unable To Accept The Court's Rejection Of The State's Legislation, The Utah Attorney General Is Resorting To Civil Litigation..."

WINT

Windtree Therapeutics shares are trading higher after the company announced it was issued an istaroxime patent for the United States for Acute Heart Failure.

Susquehanna analyst Bascome Majors maintains Greenbrier Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) with a Positive and raises the price target from $52 to $57.

Susquehanna Maintains Positive on Greenbrier Companies, Raises Price Target to $57

Press Releases

SailPoint Rolls Out Identity Security Cloud and Customer Success Program Updates to Boost Productivity and Enhance Comprehensive Identity Security

SailPoint Launches First SaaS Instance in the Middle East to Strengthen Global Strategy and Accelerate Digital Transformation

SailPoint's IdentityTV and Developer Days Return

SailPoint to Announce Fiscal First Quarter 2026 Results on June 11, 2025

SailPoint Research Highlights Rapid AI Agent Adoption, Driving Urgent Need for Evolved Security

SailPoint Strengthens South American Presence with AWS-Based SaaS Instance in Brazil

SailPoint Announces Fiscal First Quarter 2026 Results

New SailPoint and Deloitte Collaboration Helps Secure the Future of Identity Security with AI Agent Management

SailPoint's Fast-Growing Machine Identity Security Is Changing How Businesses Manage and Secure Machine Identities

Comments

SailPoint

Intérêt court

SailPoint (NASDAQ:SAIL) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL